Scale-up and Manufacturing of Self-amplifying RNA-LNPs for a COVID-19 Vaccine

preview_player
Показать описание
In this Teatime Webinar, Dr. Jason Coleman, Clinical Application Scientist Lead with Precision NanoSystems, presents on an overview of the development and scale-up activities needed to progress this saRNA vaccine to the clinic.

  1. Precision NanoSystems is now part of Cytiva
Рекомендации по теме
Scale-up and Manufacturing 0:28:21

Scale-up and Manufacturing of Self-amplifying RNA-LNPs for a COVID-19 Vaccine

Self-amplifying and messenger 0:23:40

Self-amplifying and messenger RNA for Vaccines and Therapies: Manufacturing for clinical stages

Scale Up and 0:43:13

Scale Up and Manufacturing of RNA-LNPs for a COVID-19 Vaccine

Non Viral Delivery 0:46:02

Non Viral Delivery of self amplifying mRNA Vaccines March 31 Webinar

mRNA Development and 0:07:26

mRNA Development and Manufacturing - CMC Challenges and Solutions

Standardizing Scale-up: Insights 0:38:42

Standardizing Scale-up: Insights into Producing Clinical and Commercial RNA-LNP Drug Products

Future of Pharma: 0:04:14

Future of Pharma: RNA Centre of Excellence

Novel Methods for 0:13:13

Novel Methods for Synthesizing SA RNA Vaccines Improve Yields and Accelerate GMP Manufacturing

Self Amplifying RNA 0:59:53

Self Amplifying RNA Vaccine for Prevention of COVID 19

Self-Amplifying mRNA Vaccines 1:14:21

Self-Amplifying mRNA Vaccines for Pandemic Rapid Response, presented by Dr. Andy Geall

Basics of RNA 0:40:48

Basics of RNA and RNA vaccines—Sourcing enzymes IVT

Developing Scalable RNA-LNP 0:22:07

Developing Scalable RNA-LNP Drug Products for Clinical Readiness

LNP delivery system 1:27:33

LNP delivery system for a COVID 19 self amplifying mRNA vaccine

'Next-Generation RNA Vaccines 0:11:29

'Next-Generation RNA Vaccines & Therapies' - Prof. Anna Blakney, 2022 Gairdner Laureat...

IMSE Webinar: Molecular 0:44:11

IMSE Webinar: Molecular Engineering enhances immunogenicity of self-amplifying RNA Vaccines

Self Amplifying mRNA 0:31:39

Self Amplifying mRNA vaccine for COVID 19 Dr. Anna Blakney Imperial College May 2020

CMC Considerations For 0:08:44

CMC Considerations For mRNA Manufacturing

Translating mRNA-Based Medicines 0:21:00

Translating mRNA-Based Medicines from Concept to Clinic

Precision NanoSystems' RNA 0:21:34

Precision NanoSystems' RNA Vaccine Technology

Accelerating Development of 0:28:18

Accelerating Development of saRNA-Lipid Nanoparticle Vaccines

Self-Amplifying RNA Vaccines 0:41:40

Self-Amplifying RNA Vaccines | Oxford Pharmacology Society

The new generation 0:10:03

The new generation of RNA vaccines that require ultra-low doses & help ramp up production

RNA Centre of 0:02:29

RNA Centre of Excellence: Virtual Tour

mRNA Vaccines & 0:16:00

mRNA Vaccines & Therapeutics Manufacturing with Dr. David Loong, Merck Life Science, Singapore